BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2639641)

  • 1. The model of allergic encephalomyelitis of nonacute, phase course.
    Błaszczyk B; Giełdanowski J; Viljanen MK; Dobryszycka W; Katkiewicz M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):449-58. PubMed ID: 2639641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental allergic encephalomyelitis in the chicken. Class-specific antibody to myelin basic protein, the ability of T cells to cause GvH reaction, brain and spleen histology, and nonspecific biochemical indicators of inflammation.
    Błaszczyk B; Viljanen MK; Molnar G; Giełodanowski J; Katkiewicz M; Hraba T; Krawczyk E
    Arch Immunol Ther Exp (Warsz); 1984; 32(6):703-9. PubMed ID: 6085612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
    Dimitrijević M; Rauski A; Radojević K; Kosec D; Stanojević S; Pilipović I; Leposavić G
    Eur J Pharmacol; 2007 Dec; 577(1-3):170-82. PubMed ID: 17854797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior of haptoglobin in experimental allergic encephalomyelitis in chickens.
    Woźniak M; Błaszczyk B; Krawczyk E; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):783-8. PubMed ID: 2421686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide in allergic encephalomyelitis in chickens.
    Błaszczyk B; Giełdanowski J; Viljanen M; Karakoz I; Katkiewicz M; Lemmel EM
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):369-75. PubMed ID: 3592938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azimexone and cysteine hydrazide in the treatment of allergic encephalomyelitis.
    Błaszczyk B; Giełdanowski J; Woźniak M; Dobryszycka W; Lemmel EM; Katkiewicz M; Viljanen M
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):217-27. PubMed ID: 3266915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for MHC gene control of lesion severity in experimental allergic encephalomyelitis of chickens.
    Parker MA; Schierman LW
    Prog Clin Biol Res; 1987; 238():189-98. PubMed ID: 3602006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunological reactivity in the course of allergic encephalomyelitis by isoprinosine.
    Giełdanowski J; Viljanen M; Molnar G; Błaszczyk B; Katkiewicz M; Karakoz I; Krawczyk E; Lemmel EM
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):789-96. PubMed ID: 2421687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response in chronic relapsing experimental allergic encephalomyelitis (r-EAE) in guinea pigs.
    Olsson T; Henriksson A; Link H; Kristensson K
    Prog Clin Biol Res; 1984; 146():179-86. PubMed ID: 6201888
    [No Abstract]   [Full Text] [Related]  

  • 10. Oligoclonal IgG in Lewis rats with experimental allergic encephalomyelitis.
    Whittaker KM; Whitacre CC
    Prog Clin Biol Res; 1984; 146():335-40. PubMed ID: 6201905
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic experimental allergic encephalomyelitis produced by bovine proteolipid apoprotein: immunological studies in rabbits.
    Cambi F; Lees MB; Williams RM; Macklin WB
    Ann Neurol; 1983 Mar; 13(3):303-8. PubMed ID: 6189448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental allergic encephalomyelitis in inbred lines of chickens.
    Karakoz I; Blaszczyk B; Gieldanowski J
    Folia Biol (Praha); 1977; 23(6):396-7. PubMed ID: 608475
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis.
    Raine CS; Mokhtarian F; McFarlin DE
    Lab Invest; 1984 Nov; 51(5):534-46. PubMed ID: 6208409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and biochemical studies on experimental allergic encephalomyelitis in inbred lines of chickens.
    Błaszczyk B; Giełdanowski J; Krawczyk E; Kotz J; Karakoz I; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):57-65. PubMed ID: 6604511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.
    Brown AM; McFarlin DE
    Lab Invest; 1981 Sep; 45(3):278-84. PubMed ID: 6792424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis.
    Rose LM; Richards T; Alvord EC
    Lab Anim Sci; 1994 Oct; 44(5):508-12. PubMed ID: 7844962
    [No Abstract]   [Full Text] [Related]  

  • 17. [Passive transmission of experimental allergic encephalomyelitis by serum anti-brain antibodies].
    Vilkov GA; Mezhova LI
    Biull Eksp Biol Med; 1974 Nov; 78(11):76-9. PubMed ID: 4141270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation between brain lesion lateralization and immunologic indices in a model of experimental allergic encephalomyelitis].
    Abramchik GV; Ermakova SS; Tanina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):153-9. PubMed ID: 425758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunobiological approach to the pathogenesis of experimental allergic encephalomyelitis in chickens.
    Yamaguchi Y; Niedieck B; Palacios O
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:334-44. PubMed ID: 5373032
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed, relapsing experimental allergic encephalomyelitis in mice.
    Lublin FD; Maurer PH; Berry RG; Tippett D
    J Immunol; 1981 Mar; 126(3):819-22. PubMed ID: 7462632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.